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Introduction
Dictyostelium discoideum is a social amoeba that normally 
resides in the soil on a diet of bacteria. gp130 is a surface-ex-
posed plasma membrane glycoprotein that is likely equivalent 
to gp126, which was originally postulated to be a phagocyto-
sis receptor and a component of contact site B, a cell−cell ad-
hesion system.1, 2 Antibody-induced depletion of gp130 from 
cells labeled with membrane-impermeant reagents supported 
a role in gram-negative bacterial phagocytosis,1-3 but gp130-
null cells were found to be phagocytosis competent, suggest-
ing that gp130 is not required.4 However, gp130-null cells 
exhibited a greater rate of macropinocytosis, an alternative 
feeding strategy available in the axenic mutant background of 
most laboratory strains. In addition, gp130-null cells exhibited 
enhanced cell−cell cohesion and readily formed small aggre-
gates in axenic media or after brief starvation, suggesting de-
creased repulsion exhibited by wild type cells. Levels of gp130 
and its transcript declined as normal cells underwent starva-
tion-induced aggregation and development,4 consistent with 
a contact inhibition role during growth. gp130 is related to a 
family of 4 gp138 cell surface glycoproteins implicated in sex-
ual cell fusion5-7 and cell−cell interactions8, 9 and 10 other pre-
dicted proteins (see below), suggesting an even larger role 
for this class of proteins in cell−cell and cell−environment 
transactions.
Gene sequencing predicted that gp130 has an unprocessed 
Mr of 81 666, but antibodies against recombinant gp130 iden-
tified a plasma membrane and cell surface associated protein 
with an apparent Mr of 130 000 based on SDS-PAGE. The pre-
dicted coding sequence contains 18 N-glycosylation sequons, 
a sequence motif (Asn-X-Ser/Thr, where X ≠ Pro) that is a 
candidate for N-glycosylation. Biochemical analyses showed 
that gp130 binds the lectin Concanavalin A (Con A), suggest-
ing that the apparent Mr discrepancy may be explained by ex-
tensive N-glycosylation. Sequence analyses also predict that 
gp130 is directed to the secretory pathway by a cleavable sig-
nal peptide, and contains a cleavable C-terminal signal that di-
rects the attachment for a GPI-anchor. These signals are ex-
pected to expose the entire coding region to glycosylation 
processing pathways and present gp130 at the cell surface. Al-
though the gp130 polypeptide possesses several amino acid 
repeat motifs, sequence comparisons have not identified any 
clear homologies to aid in dissecting the function of gp130.
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Abstract
Genetic analysis has implicated the cell surface glycoprotein gp130 in cell interactions of the social amoeba Dictyostelium, and in-
formation about the utilization of the 18 N-glycosylation sequons present in gp130 is needed to identify critical molecular deter-
minants of its activity. Various glycomics strategies, including mass spectrometry of native and derivatized glycans, monosac-
charide analysis, exoglycosidase digestion, and antibody binding, were applied to characterize a nonanchored version secreted 
from Dictyostelium. s-gp130 is modified by a predominant Man8GlcNAc4 species containing bisecting and intersecting GlcNAc 
residues and additional high-mannose N-glycans substituted with sulfate, methyl-phosphate, and/or core α3-fucose. Site map-
ping confirmed the occupancy of 15 sequons, some variably, and glycopeptide analysis confirmed 14 sites and revealed exten-
sive heterogeneity at most sites. Glycopeptide glycoforms ranged from Man6 to Man9, GlcNAc0−2 (peripheral), Fuc0−2 (including 
core α3 and peripheral), (SO4)0−1, and (MePO4)0−1, which represented elements of virtually the entire known cellular N-glycome 
as inferred from prior metabolic labeling and mass spectrometry studies. gp130, and a family of 14 related predicted glyco-
proteins whose polypeptide sequences are rapidly diverging in the Dictyostelium lineage, may contribute a functionally impor-
tant shroud of high-mannose N-glycans at the interface of the amoebae with each other, their predators and prey, and the soil 
environment.
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In part on the basis of the projected number of glycans and 
their likely presentation on the exterior of gp130, we propose 
that the glycans themselves contribute to its suspected roles 
in cell interactions and endocytosis. This hypothesis is con-
sistent with the thick glycocalyx present at the cell surface of 
the amoebae,10 poor conservation of the gp130-polypeptide se-
quence in related species as reported here, and evidence for 
extensive N-glycosylation differences among different so-
cial amoebae.11 Previous studies of D. discoideum have impli-
cated glycoproteins and oligosaccharide moieties in cell adhe-
sion,12-16 phagocytosis17 and sexual development.18-20 Classical 
methods21 and a recent mass spectrometry-based study22 de-
scribe major features of the D. discoideum N-glycome, but it is 
not known which are presented at the cell surface. Here we 
apply a mass spectrometry-based approach to analyze the N-
glycans on a secreted recombinant version of gp130. Although 
the protein expresses a predominant high-mannose N-glycan 
with bisecting and intersecting GlcNAc-residues, its N-gly-
cans are extensively microheterogeneous and include sulfated 
and phosphorylated N-glycans described by classical pre-
mass spectrometry approaches.21 Analysis of the glycopepti-
dome confirmed the observations and mapped the distribu-
tion of glycoforms over 15 of the 18 candidate glycosylation 
sites. The glycan map will inform future strategies to investi-
gate the role of gp130 glycans in cell surface functions.
Experimental Procedures
Cell Strains and Cell Culture. Strains HL250 (modC) and 
HW11 (modB), derived from Ax3, DBS0235414 (gp130-null) and 
CC11 (s-gp130 producer), derived from DH1, and Ax2, were 
grown axenically in shaking HL-5 culture medium at 22 °C.23
Cloning of gp130 cDNA.  gp130 cDNA was gener-
ated from an oligo dT-primed reverse transcriptase reac-
tion using total RNA isolated from growth-phase strain Ax2 
with TRIZOL Reagent (Invitrogen), followed by PCR am-
plification using Taq polymerase and gene specific primers 
5′-AAATGAAAAAAAATTATTTATTTTTAT and 5′-TCACTT-
TACCAAAATAATGTAA. The product was cloned into pST-
Blue-1 (Novagen), and its translated sequence (GenBank 
AAK69771) was identical to the splice model at Dictybase.org 
(DDB0214937).
s-gp130 Expression.  The coding region for the predicted 
polypeptide after cleavage of the N- and C-terminal signal 
peptides was amplified from pSTBlue-gp130 using CD11F, 
5′-AGTGGATCCGGACAAACAAAACCACTTCCATCA-
GATCAAATGGAA, and CD11R, 5′-AGTGGATCCATCAT-
GACCATTTTCTTCAGAGGATGT. The BamH1-digested gel-
purified PCR product was directionally cloned into the BglII 
site of pVS,23 and pVS-CD11 was electroporated into the 
gp130-null strain DBS0235414.4 Producers were selected in 20 
μg/mL G418 and clones were screened using silver-stained 
SDS-PAGE gels. Clone CC11 was used for the present study.
s-gp130 Purification.  Strain CC11 was grown in HL-5 to 
stationary phase. The culture supernatant was obtained by 
centrifugation at 300× g for 10 min, brought to 50% (w/v) 
(NH4)2SO4 at 4 °C and centrifuged at 10 000× g for 20 min. The 
pellet was resuspended in 20 mM Na phosphate, pH 6.8, and 
dialyzed against wash buffer (500 mM NaCl, 20 mM Tris-HCl, 
pH 7.4). The sample was clarified at 10 000× g for 10 min and 
applied to a column of Con A-agarose (Sigma, St. Louis, MO) 
equilibrated in wash buffer at 4 °C, washed, and eluted with 
0.2 M α-methyl-mannoside in wash buffer at 22 °C. The elu-
ate was dialyzed at 4 °C against 20 mM sodium phosphate, 
pH 6.8, and clarified again by centrifugation. The sample was 
adjusted to 50% (w/v) (NH4)2SO4 and loaded onto a phenyl-
Sepharose High-performance Hi-trap column (low sub; GE 
Healthcare) equilibrated in 50% (w/v) (NH4)2SO4 in 100 mM 
Tris-HCl, pH 7.5, at 22 °C. The column was eluted with a de-
scending step gradient of (NH4)2SO4. The 30−25% (NH4)2SO4 
fractions, which contained gp130 based on Western blot-
ting, were dialyzed against 100 mM Tris-HCl, pH 7.5, diluted 
5-fold, applied to a Q-Sepharose (GE Healthcare) column 
equilibrated in 20 mM Tris-HCl, pH 7.5, and eluted in an as-
cending step gradient of KCl in the same buffer. The 0.2−0.3 
M KCl fractions were concentrated in a Centricon-100 cen-
trifugal concentrator (Millipore), and applied to a Superdex 
200 (1.6 × 60 cm, GE Healthcare) column equilibrated in 20 
mM NH4HCO3, pH 7.8. s-gp130 eluted as a single symmetri-
cal peak, at a final yield of 80 μg from 1750 mL of culture me-
dia. s-gp130 behaved as a single population during each step 
of purification. Sugar composition and glycomic profiles were 
confirmed in independent preparations.
Butanol-Extraction of GPI-anchored Proteins and Purifi-
cation of gp130.   The particulate fraction (P100) of strain Ax3 
was isolated by centrifugation of filter-lysed cells at 100 000× 
g for 1 h,24 and resuspended at 2.5 mg protein/mL in 10 mM 
sodium citrate (pH 5.5) at 4 °C. Three-fourths volume of cold 
n-butanol was added to the resuspended membranes and ag-
itated for 5 min at 4 °C.25 The resulting solution was centri-
fuged 10 000× g for 30 min to form three layers. The butanol 
saturated aqueous lower layer was applied at 4 °C at 2.5 mL/
min to a 5-mL High Trap Sepharose Q column (GE Health-
care) pre-equilibrated in load buffer (20 mM Tris-HCl, pH 7.5) 
and eluted with an ascending gradient to 1 M NaCl in load 
buffer containing 0.2% octyl-glucoside. gp130 eluted as a sin-
gle peak at 450 mM NaCl based on Western blot analysis 
with rabbit anti-gp130.
SDS-PAGE and Western Blotting.  Proteins were electro-
phoresed on SDS-PAGE gels, and either semi-dry transferred to 
0.45 μm pore size nitrocellulose (Bio-Rad),24, 26 or silver-stained 
as described27 except that 0.1% silver nitrate was supplemented 
with 0.08% formalin. gp130 and s-gp130 were probed with rab-
bit anti-gp130 Ab4 followed by detection with Alexa 680-con-
jugated antirabbit IgG (Invitrogen). myc-tagged s-gp130 was 
probed with mAb 9E10 followed by Alexa 680-conjugated an-
timouse Ab (Invitrogen). To detect Fuc, s-gp130 (2 μg), total 
membranes of axenically grown or 16 h-starved Ax3 cells (30 
μg protein), and the n-butanol extract (10 μg protein), were sub-
jected to SDS-PAGE and Western blotted with a core α3-linked 
fucose specific antibody, prepared from rabbit anti-Horseradish 
peroxidase (HRP) (Jackson ImmunoResearch) by affinity purifi-
cation against HRP, as described.28, 29
Monosaccharide Composition Analysis by HPAEC-PAD30. 
Purified s-gp130 (10 μg) and a reagent blank were vacuum-
dried in 1.5-mL conical polypropylene tubes (Eppendorf) and 
incubated in 200 μL of 4 M TFA at 100 °C for 4 h. TFA was re-
moved by centrifugal evaporation, and the sample was resus-
pended in water and analyzed by HPAEC using a Carbo-Pac 
PA-1 (Dionex) column on a Dionex DX-600. The column was 
eluted isocratically with 14 mM NaOH for 20 min and then with 
an ascending gradient of sodium acetate (0−500 mM) in 100 mM 
NaOH for 50 min. Monosaccharides, observed by pulsed am-
perometric detection (PAD), were identified based on elution 
time, and quantitated by comparison of PAD values to a stan-
dard curve for each monosaccharide (Dionex). Values for glu-
cose, which were similar to the value in the reagent blank, were 
assumed to reflect environmental contamination.
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Amino Acid Analysis.  Purified s-gp130 ( 40 μg) was sup-
plemented with beta-thienyl alanine (4 nmol), dried, and in-
cubated in 6 N HCl in sealed evacuated tubes for 24 h at 110 
°C. Amino acids were resolved by cation exchange chroma-
tography and detected by online post column derivatization 
with ninhydrin in the OUHSC Proteomics facility. Total pro-
tein concentration was extrapolated from the average of val-
ues, corrected by molar ratios, for the stable amino acids.
Protease Digestions.  Ten micrograms of purified s-gp130 
was brought to 6 M urea in 25 mM NH4HCO3 buffer (pH 7.8), 
10 mM dithiothreitol, and heated at 60 °C for 30 min. The sam-
ple was alkylated by the addition of iodoacetamide to a concen-
tration of 30 mM and incubated for 30 min at 22 °C, followed by 
the addition of dithiothreitol to a final concentration of 40 mM. 
After further incubation for 30 min, the sample was diluted 
8-fold with 25 mM NH4HCO3 (pH 7.8). Alkylated s-gp130 was 
treated with sequencing grade trypsin (1:50 enzyme:substrate) 
(Promega, Madison, WI) at 37 °C for 18 h. Half of the sample 
was subsequently treated with chymotrypsin (Sigma, St. Louis, 
MO; 1:50 enzyme to substrate ratio) at 37 °C for 18 h. Pepsin 
(Amresco, Solon, OH) digestion was conducted in 0.5% formic 
acid at 1:50 enzyme:substrate at 37 °C for 4 h.
Enzymatic Deglycosylation. For N-glycan release from 
protein, alkylated s-gp130 was diluted in glycoprotein de-
naturation buffer containing SDS (New England Biolabs), 
boiled for 10 min, diluted with G7 reaction buffer contain-
ing 1% NP40, and treated with 50 U PNGase F/μg protein for 
18 h at 37 °C. Alternatively, alkylated s-gp130 was diluted to 
0.8 M urea with 25 mM NH4HCO3 (pH 7.8), and treated with 
PNGase F as above. Partially purified gp130 was concentrated 
and buffer exchanged to 50 mM Na citrate (pH 5.5), 0.25% 
SDS, using a Microcon 100 centrifugal concentrator (Amicon), 
heated at 60 °C for 15 min, adjusted to 1% NP40, 0.125% SDS, 
and treated with 500 U Endoglycosidase Hf (Endo Hf, 500 U, 
NEB)/20 μL reaction at 37 °C for 18 h.
For release from peptides, tryptic and/or chymotryptic 
peptides were adsorbed to a pre-equilibrated (MeOH to H2O 
to 50% ACN, 0.1% TFA in H2O to 0.1% TFA in H2O) SepPak 
C18 cartridge (Waters) and eluted stepwise with 50% ACN, 
0.1% TFA in water, and 80% ACN, 0.1% TFA in water, dried in 
vacuo, resuspended in PNGase F buffer, and digested as above. 
For PNGase A digestion, peptic peptides were dried in vacuo 
and resuspended in 50 mM citrate/Na phosphate buffer (pH 
5.0) and treated with 50 μU PNGase A (Roche)/25 μL reaction 
for 18 h at 37 °C. N-glycans were collected as the flow-through 
fraction from a pre-equilibrated (see above) SepPak C18 car-
tridge and applied to a pre-equilibrated Carbograph cartridge 
(Grace Davison, Deerfield, IL), and washed extensively with 
water. N-glycans were eluted with 50% ACN, 0.1% TFA in 
water. For Endo Hf digestion, tryptic peptides were dried and 
resuspended in 50 mM Na citrate buffer (pH 5.5) and treated 
with 500 U Endo Hf/20 μL reaction volume for 18 h at 37 °C.
Affinity Selection of Glycopeptides.  Glycopeptides from 
proteolytic digests were enriched by hydrophilic interac-
tion chromatography or by lectin Concanavalin A (Con A) se-
lection. For the former, polyHYDROXYETHYL A TopTips 
(PolyLC, Columbia, MD) were pre-equilibrated with load-
ing buffer (80% ACN, 0.5% formic acid, 19.5% H2O). Lyophi-
lized, digested s-gp130 peptides (10 μL) were resuspended in 
loading buffer and applied. Unbound peptides were washed 
from the microcolumn with 5 column volumes of loading buf-
fer. Glycopeptides were eluted with three column volumes of 
0.5% formic acid in H2O and dried in vacuo. For Con A affin-
ity selection, glycopeptides were applied to a SepPak C18 car-
tridge, eluted and dried as above, resuspended in binding buf-
fer (10 mM HEPES-NaOH, pH 7.5, 1 mM CaCl2, 1 mM MnCl2), 
and incubated with 200 μL of Con A agarose beads (10 mg/
mL Con A, Vector Laboratories) for 1 h at 22 °C with rocking. 
The slurry was transferred to a Bio-Rad Econocolumn, and 
nonglycosylated peptides were removed by the addition of 10 
bed volumes of binding buffer. Glycopeptides were eluted us-
ing 3 bed volumes of 0.2 M α-methyl mannoside in binding 
buffer and desalted using a C18 SepPak.
Exoglycosidase Digestion.  On target exoglycosidase di-
gestions of s-gp130 N-glycans were adapted from other pro-
tocols.31-33 Briefly, purified 2AB-labeled glycans in 50% meth-
anol were spotted directly onto polished steel MALDI target 
plates with an equal volume of 10 mg/mL 6-aza-2-thiothy-
mine in water matrix solution. Spots were dried under vac-
uum and resuspended in 1 μL of 50 mM NH4Ac (pH 5.0) at 
10 U/ml jack bean β-hexosaminidase or α-mannosidase (Pro-
zyme, Hayward, CA). The plates were incubated at 37 °C in a 
humidified box for 2, 4, or 24 h. Similar results were obtained 
with reactions conducted in microtubes in the absence of ma-
trix (not shown).
Reductive Amination of N-Glycans.34   Purified PNGase F-
released glycans from s-gp130 were dried in vacuo in a 1.5 mL 
microcentrifuge tube and resuspended in 10 μL of 0.4 M 2AB 
in DMSO/glacial acetic acid (7:3). After 30 min incubation at 
80 °C, 10 μL of 2 M sodium cyanoborohydride in the same sol-
vent was added and incubation continued for an additional 90 
min. Reactions were spotted directly onto Whatman 3MM pa-
per and dried. Paper chromatograms were developed using n-
butanol:ethanol:water (4:1:1) and air-dried. Spot origins were 
excised and labeled glycans eluted using 400 μL H2O.
Reversed-Phase HPLC of 2AB-Labeled Glycans.  2AB-
labeled glycans (10−20 pmol) were eluted isocratically in 3% 
ACN, 0.5% acetic acid in water from a C18 4.6 × 250 mm col-
umn (Vydac Peptide/Protein C18 218TP54) at 0.2 mL/min. 
Fractions were collected every minute, dried in vacuo, and re-
suspended in 5 μL of 50% methanol/50% water for MALDI-
TOF-MS analysis.
Permethylation of Glycans.  Spin column permethylation 
was performed as described.35 As an alternative to liquid−
liquid extraction, the permethylation reaction was subject to 
solid-state extraction on a C18 cartridge,36 which was eluted 
stepwise with 5, 15, 35, 50, and 80% ACN with 0.1% TFA in 
H2O. Samples were dried and resuspended in 10 μL of 50% 
methanol/50% H2O for MS analysis. Similar results were ob-
tained for either method (not shown).
O-Glycan Analysis.  A pepsin/PNGase A digest was sub-
jected to conventional reductive β-elimination37 and spin col-
umn permethylation,38 and analyzed by MALDI-TOF-MS.39 
Alternatively, nonreductive, NH3-based β-elimination of gly-
cans40 from PNGase F-treated tryptic peptides was followed 
by 2AB labeling34 and analysis by MALDI-TOF-MS and RP-
HPLC chromatography.41
MALDI-TOF/TOF-MS. MALDI-TOF-MS analyses of pep-
tide and glycans were performed on an Ultraflex II (Bruker 
Daltonics, Billerica, MA) with a LIFT apparatus for TOF/TOF 
experiments. Samples were spotted with an equal volume of 
2,5-dihydroxybenzoic acid matrix for glycans (20 mg/mL in 
50% ACN, 0.1% TFA in H2O) or α-cyano-4-hydrocinnaminic 
acid for glycopeptides (10 mg/mL in 50% ACN, 0.1% TFA in 
H2O) and vacuum-dried. Glycans were also routinely screened 
using utilizing 2′,4′,6′-trihydroxyacetophenone monohydrate 
as an alternative matrix. A dextrin ladder was used as an ex-
ternal mass calibrant (Mr 500−3000, V-laboratories, Covington, 
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LA) for glycan samples and a seven-component peptide mix-
ture (Bruker Daltonics) was used for glycopeptides. Mass ac-
curacy was typically <50 ppm for glycans and <100 ppm for 
glycopeptides. The instrument was operated in reflectron pos-
itive ion mode with an accelerating voltage of 25 kV, except 
as indicated. MALDI-TOF/TOF spectra were acquired at 66 
Hz laser frequency and 1000−5000 individual spectra were 
summed; precursor ions were accelerated to 8 kV and selected 
by a timed ion gate. Fragment ions generated by laser-induced 
dissociation were subsequently accelerated at 19 kV by the 
LIFT apparatus. High energy CID was performed using Ar as 
the collision gas.
nanoLC−MS/MS.  Two μg of total trypsin digest was 
loaded onto a C18 column (Acclaim PepMap100 C18, 3 μm, 100 
Å pore) pre-equilibrated in Buffer A, and peptides were eluted 
with a linear gradient of 10−70% buffer B in 40 min (Buffer A: 
2% ACN, 0.09% formic acid, 0.01% TFA in H2O; Buffer B: 95% 
ACN, 0.09% formic acid, 0.0085% TFA in H2O). The nanoLC 
(Ultimate 3000 nanoLC system; Dionex, Sunnyvale CA) was 
directly infused into a QSTAR Elite (Applied Biosystems) (ion 
spray voltage: 2500 V, ion source gas: 22 psi, curtain gas: 20 
psi), such that peak width was 30 s. The QSTAR elite was ex-
ternally calibrated daily with a four peptide mixture (range 
498−1063 m/z). Data-dependent MS/MS fragmentation of pre-
cursor ions was performed on the top 3 ions with a 250 s ex-
clusion time (survey: 620−3300 m/z with charge 2 to 5 if signal 
exceeds 10 cts). Mass accuracies, typically <250 ppm for glyco-
peptides, are listed in Table 5.
Alternatively, 2 pmol of a pepsin or trypsin-chymotrypsin 
digest (with or without Con A enrichment) was introduced 
into a C18 column (self-packed into New Objective PicoTip) 
mounted on a splitless Eskigent nanoLC 1D (Dublin, CA), pre-
equilibrated with 2% buffer B (Buffer A: 0.1% formic acid in 
H2O and Buffer B: 2% H2O, 0.1% formic acid in ACN). Pep-
tides were eluted with a 2−70% linear gradient of buffer B over 
45 min and directly infused into a LTQ XL (Thermo-Electron, 
Waltham, MA). A survey scan of the range from 300−1800 m/z 
was performed for each time interval, followed by data-de-
pendent MS/MS fragmentation on the top three ions with a 
120 s exclusion time. Mass accuracy was typically <500 ppm 
for glycopeptides.
Results
s-gp130 Expression and Purification.  The gp130 coding se-
quence contains a predicted N-terminal cleavable signal peptide 
and a C-terminal cleavable signal for the addition of a GPI-an-
chor. To produce sufficient gp130 for glycosylation analysis, the 
coding sequence of the predicted processed polypeptide was 
cloned into a standard expression vector for secretory proteins, 
pVS.23 The resulting s-gp130 protein consisted of an N-terminal 
cleavable signal peptide derived from celA, the predicted pro-
cessed gp130 polypeptide, and a C-terminal c-myc epitope tag 
that replaced the putative GPI-anchor signal. Modifications to 
the original sequence are indicated in Figure 1.
When expressed in gp130-null cells, s-gp130 was readily de-
tected in the growth medium by SDS-PAGE and purified as a 
single protein population over columns of Concanavalin A, 
phenyl Sepharose, and Q-Sepharose (see Experimental Proce-
dures). s-gp130 eluted as a symmetrical peak during the final 
gel filtration purification step (Figure 2A), and SDS-PAGE con-
firmed that the great majority of protein migrated at the posi-
tion of s-gp130 (Figure 2B). Probing of a Western blot with anti-
gp130 antiserum (Figure 2C, lane U) identified the same profile 
of major and minor bands, which confirmed the identity of the 
major band, and indicated that the minor bands in the silver 
stained gel represented electrophoretic variants of s-gp130. The 
purity of the preparation was confirmed by the absence of non-
Figure 1. Sequences of gp130 and s-gp130, and summary of glycosylation site occupancy. The gp130 sequence is shown in black. Recombi-
nant gp130 (s-gp130) is identical except at the termini, where black italicized gp130 sequences are replaced by the sequences below in pur-
ple. These changes are predicted to extend the N-terminus with a DRSG tetrapeptide after signal sequence processing, and replace the puta-
tive C-terminal GPI anchor processing sequence with a c-myc epitope tag. These changes, and 85% of the predicted s-gp130 sequence were 
confirmed by the MS studies described below (amino acids not detected are in gray). Predicted N-glycosylation sites (N-sequons) are under-
lined/bolded and colored according to experimental data indicating full occupancy (green), partial occupancy (blue), or unoccupied (black), 
as summarized in Table 4 below.
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gp130 Dictyostelium peptide sequences in MASCOT searches 
of the proteomic data (below, not shown). The s-gp130 band 
labeled with mAb 9E10 (not shown), which recognizes the C-
terminal c-myc epitope tag, and exhibited an apparent Mr in-
distinguishable from that of endogenous gp130 (Figure 2E), in-
dicating a similar degree of overall glycosylation.
s-gp130 is Highly N-glycosylated.  The predicted sequence 
of gp130 contains 18 N-sequons (N-x-S/T where x ≠ P) as po-
tential sites of N-glycosylation, as shown in Figure 1. Treat-
ment of s-gp130 with PNGase F (which cleaves the GlcNAc-
Asn linkage) reduced its apparent Mr by 29,000, from 133
000, based on SDS-PAGE (Figure 2C, Table 1), consistent with 
the loss of 14 N-glycans with an average Mr of 2,124 (see be-
low). However, Mr estimates based on SDS-PAGE are subject 
to error, and an average apparent Mr of 115,000 for s-gp130 
was estimated by MALDI-TOF-MS (Table 1). Interestingly, 
s-gp130 became more heterodisperse after PNGase F treatment 
(Figure 2C), unlike control incubations lacking PNGase F, re-
gardless of whether s-gp130 was denatured with SDS or urea, 
or subjected to varied PNGase treatments (different amounts, 
multiple additions, longer incubation periods). This suggested 
that varying numbers per polypeptide of additional, PNGase 
F-resistant N-glycans may occur on s-gp130, and that the to-
tal number of N-glycans per polypeptide was more constant. 
Similar results were seen after release of N-glycans from either 
s-gp130 or partially purified gp130 using Endo H ((Figure 2F), 
which cleaves between the 2 core GlcNAc residues, indicating 
that this feature is also shared with native gp130.
The total sugar content of s-gp130 was determined before 
and after PNGase F digestion by HPAEC-PAD analysis of acid 
hydrolysates. s-gp130 contained Fuc, glucosamine (assumed 
to derive from GlcNAc), and Man in a 0.1:1.0:1.5 molar ratio 
(Table 2). Acidic sugars were not detected. Based on amino 
acid analysis and assuming an average of 3 GlcNAc/N-gly-
can (see below), N-glycans numbered 13.7/polypeptide, con-
sistent with the estimate above. Glycans removed by PNGase 
F contained GlcNAc and Man (1:1.7 molar ratio), and a trace of 
Fuc. However, about 17% of the monosaccharides (11% of to-
tal initially measured) were detected after PNGase F deglyco-
sylation and contained Fuc, GlcNAc and Man (0.2:1:1.8 molar 
ratio). The composition of residual sugars was consistent with 
an average of 2 additional fucosylated N-glycans/polypep-
tide, expected to be resistant to PNGase F-release if Fuc were 
α3-linked to the core GlcNAc as previously described.22, 29
No evidence for O-glycans was observed using reductive 
β-elimination with sodium hydroxide followed by permethyl-
ation, or NH3-based β-elimination followed by 2AB labeling, 
RP-HPLC and fluorescence detection (data not shown). Fur-
thermore, the apparent Mr of gp130 in modB- and modC mu-
tant strains, which are defective in global mucin-type O-gly-
cosylation23, 26 or fucosylation42 respectively, was unaffected, 
within the resolution and detection limits of SDS-PAGE and 
Western blotting (Figure 2E). Thus, unlike D. discoideum spore 
coat proteins previously analyzed by these methods,42, 43 
gp130 and s-gp130 are not extensively, if at all, O-glycosylated.
Figure 2. SDS-PAGE analysis of s-gp130 glycosylation. (A) A280 trace from final gel filtration step of the purification. (B) Silver-stained SDS-
PAGE (7−20% acrylamide for panels B−D) analysis of fraction 56 shown in panel A. Lanes represent 2-fold serial dilutions. (C) Western blot 
of untreated s-gp130 (U), or s-gp130 treated with 1 or 3 μL of PNGase F (F1 or F3), probed with anti-gp130. (D) Western blot analysis of total 
membranes of vegetative stage strain Ax3 (v) or 16 h developed strain Ax3 (d), an n-butanol extract of vegetative cell membranes (b), or puri-
fied s-gp130 (fraction 56), with an antibody against the core α3-Fuc epitope. (E) Comparison of s-gp130 with gp130 from normal cells and O-
linked glycosylation mutants. SDS/PAGE (7.5% acrylamide)/Western blot of extracts (100 μg protein) of the gp130-KO strain (KO), normal 
strain Ax3 (a), the modB mutant strain HW11 (b), the modC/gmd mutant strain HL250 (c), and strain CC11 expressing s-gp130 (s), were probed 
with anti-gp130. Two blots, aligned by replicates of sample a, are merged. (F) s-gp130 and partially purified gp130, before and after digestion 
with Endo H, were separated on a 4−12% Bis-Tris SDS-PAGE gel, and Western blotted using anti-gp130.
Table 1. Mr Measurements of gp130 and s-gp130
                                                                   apparent Mr
                 calculated                SDS-PAGE                  MALDI-TOF-MS
sample   polypeptide Mr        untreated      PNGaseF         untreated
gp130 79 864a 130 000	 −	 −
s-gp130 81 666b 133 000 104 000 115 000
a. After processing of N- and C-terminal signals, but not including po-
tential GPI anchor.
b. After processing of N-terminal signal.
Table 2. Monosaccharide Composition of s-gp130
                                       monosaccharide,                        ratio of 
                                             pmols                             monosaccharides
sample                        Fuc    GlcNa               Man            Fuc   GlcNa  Man
Untreated s-gp130 160 1530 2240 0.1 1.0 1.5
PNGase F-released  30 970 (63%) 1620 (71%) 0.0 1.0 1.7 
    glycans 
PNGase F-treated  34 177 (11%) 320 (8%) 0.2 1.0 1.8 
    s-gp130 
a. GlcN = glucosamine, derived from GlcNAc by acid catalyzed 
de-N-acetylation.
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N-Glycans from s-gp130.   PNGase F-released glycans 
were recovered, permethylated, and profiled by MALDI-TOF-
MS. A series of sodium-adducted ions was observed that cor-
responded to N-glycans with varying hexose (H═Hex) and 
N-acetylhexosamine (N = HexNAc) compositions. The most 
abundant species matched a glycan with the composition 
of H8N4, with less intense signals corresponding to H8N3, 
H8N2, and H9N3 (Figure 3C). N-glycans were also analyzed 
without permethylation after labeling their reducing termini 
with 2AB (Figure 3B), which yielded a similar profile except 
for the addition of H7N4. Direct analysis of underivatized N-
glycans revealed, in addition to these neutral glycans, lower 
abundance species that appeared to be sulfated or methyl-
phosphorylated (Figure 3A), as discussed below. The ma-
jor ions of each of the three spectral profiles corresponded to 
the same predicted glycan compositions, so relative preva-
lence did not result from a bias resulting from derivatization. 
Based on the monosaccharide composition analysis, H8N4 
was assigned as Man8GlcNAc4, with less abundant ions cor-
responding to species containing 2−4 GlcNAc residues and 
7−9 Man residues. Predicted structures in Figure 3 are based 
on prior evidence that Dictyostelium forms the traditional Man-
9GlcNAc2 structure after deglucosylation.21 Man8GlcNAc2 is 
depicted as the product of ER-mannosidase-I acting on the B-
arm,44 but the possibility that Man removal occurs from the A-
arm (α3Man-linked) cannot be excluded.45 Positions of the pe-
ripheral GlcNAc residues are discussed below.
To search for potential PNGase F-resistant N-glycans, 
s-gp130 was digested with pepsin and PNGase A, an N-glyca-
nase that preferentially acts on short peptides and can cleave 
N-glycans modified with α3-Fuc on the reducing end GlcNAc. 
N-glycans released by this method were similar to the PNGase 
Figure 3. Glycomic analysis of N-glycans from s-gp130. (A) N-glycans were released by PNGase F from trypsin-treated s-gp130 and profiled 
by MALDI-TOF-MS in positive ion mode. (B) N-glycans were conjugated with 2AB prior to MS analysis. (C) N-glycans were permethylated 
prior to analysis. The similarity of the profiles obtained is emphasized by differential compression of m/z scales to compensate for mass dif-
ferences contributed by the derivatizations. The composition of the major species is H8N4 (H = Hexose, N = N-acetyl-Hexosamine, dH = de-
oxyHexose) which, based on the monosaccharide composition analysis (Table 2) and other data (below), was assigned as Man8GlcNAc4. (D) 
Similar analysis of permethylated N-glycans released by PNGase A from pepsin-digested s-gp130, revealing additional low abundance fu-
cosylated species. All ions were singly charged and monosodiated with the exception of the sulfated and methyl-phosphorylated ions in 
panel A, which were [M + 2Na − H]+, as listed in Table 3. Models depicting the most likely structure corresponding to each composition (see 
text and below) employ Consortium for Functional Glycomics (http://www.functionalglycomics.org/static/consortium/) notation.
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F-released glycans, with Man8GlcNAc4 and Man8GlcNAc3 be-
ing the most prevalent glycans detected (Figure 3D). In addi-
tion, related species assigned as Man8GlcNAc4Fuc and Man-
8GlcNAc3Fuc were detected at lower abundance. Since known 
peripheral Fuc linkages do not interfere with PNGase F cleav-
age, and a core α1,3-fucosyltransferase activity and core α3-
linked Fuc have been detected in Dictyostelium,29, 22 these 
monofucosylated species were predicted to contain the core 
Fucα1,3GlcNAc linkage as depicted in Figure 3D. Consistent 
with this model, core-linked Fuc was detected during MS/MS 
analysis of a glycopeptide containing site 7 (see below). To con-
firm occurrence of the α3-linkage, s-gp130 was probed with an-
tisera against HRP, a glycoprotein with immunogenic α3-linked 
core Fuc on its N-glycans.46 An affinity-purified fraction reacted 
specifically with s-gp130 (Figure 2D), but an affinity-depleted 
fraction did not (not shown). Since s-gp130 expresses the HRP-
fucose epitope, Fuc is likely α3-linked to the core GlcNAc. The 
most highly reactive band of vegetative cell membranes and 
an n-butanol extract enriched in GPI-anchored membrane pro-
teins (lanes v and b) comigrated with gp130. Thus, gp130 may 
be the major carrier of core-fucosylated N-glycans in vegetative 
cells. As expected,22, 29 developing cells (lane d) expressed much 
higher levels of core-fucosylated N-glycans.
High-Mannose Glycans with Terminal GlcNAc Moi-
eties at Branched Man Residues.  Previous studies described 
a Man8GlcNAc3 species consisting of a canonical high-man-
nose glycan substituted with a GlcNAc residue β4-linked to 
the α6-Man linked to the β-Man (intersecting),45 and a Man-
8GlcNAc4 species containing both the intersecting GlcNAc and 
a β4-GlcNAc on the β-linked Man (bisecting).47 A recent MS-
based glycomics analysis confirmed the existence of this spe-
cies.22 To address the similarity of Man8GlcNAc4 on s-gp130 
to this structure, Man8GlcNAc4-2AB was isolated by RP-HPLC 
and digested with Jack Bean β-hexosaminidase or Jack Bean 
α-mannosidase. Man9GlcNAc3-2AB was analyzed for compar-
ison. The glycans were unaffected by β-hexosaminidase (data 
not shown), as expected if the GlcNAc residues were located 
at bisecting or intersecting positions protected from enzyme 
access. Three major products [H(5-7)N4-2AB] were observed 
after α-mannosidase digestion of Man8GlcNAc4-2AB (Figures 
S1A and B, Supporting Information). The smallest product, 
H5N4-2AB, likely resulted from inaccessibility of the remain-
ing mannoses due to steric interference by intersecting and bi-
secting GlcNAc residues. This assignment is supported by de-
tection of a prominent ion corresponding to H3N4-2AB in an 
MS/MS-CID experiment like that shown in Figure 4 (below). 
Partial steric interference by the GlcNAc residues may result 
in partial accumulation of larger products, which were reliably 
detected in multiple trials using the highest α-mannosidase 
amounts tolerated by MS protocols, as also observed previ-
ously.22, 48 α-mannosidase may also be susceptible to product 
inhibition by free Man. Digestion of Man9GlcNAc3-2AB with 
α-mannosidase yielded a mixture of H(4-6)N3-2AB species 
(Supplementary Figure S1C and D, Supporting Information). 
The presence of H4N3-2AB is most consistent with an inter-
secting GlcNAc in the original structure.
Further information about the positions of the GlcNAc 
residues was inferred from diagnostic fragment ions from 
MALDI-TOF/TOF CID experiments. The [M + Na]+ ion of 
Man8GlcNAc4-2AB yielded B and Y type fragment ions that 
demonstrated a series of Man and GlcNAc losses (Figure 4). 
In the low m/z range, two B type ions 163.15 and 204.17 indi-
cated terminal Man and GlcNAc respectively. Also observed 
were ions m/z 325.18, a B fragment ion of 2 Man, and a weak 
ion at 487.5 corresponding to B ion of 3 Man. Fragment ions 
528.23 (H2N1−2AB) and 690.24 (H3N1-2AB) were most consis-
tent with substitution of GlcNAc at the intersecting position. 
The ion at m/z 893.3 matches H1N3-2AB, which indicated a 
bisecting GlcNAc on the core β-mannose. The presence of the 
H3N4-2AB ion at m/z 1401.5 was most consistent with substi-
tution of peripheral GlcNAcs at both intersecting and bisect-
ing GlcNAcs. Although the possibility that GlcNAc is terminal 
to monosubstituted Man was not excluded by the fragment 
profile, this configuration would be expected to be sensi-
tive to β-hexosaminidase digestion, which was not observed 
(see above). Thus the Man8GlcNAc4 isomer found on s-gp130 
likely corresponds to the bisecting/intersecting GlcNAc struc-
ture previously described on bulk N-glycans.45, 47, 22
Sulfated and Phosphorylated N-Glycans. To investigate 
the possibility of additional glycan types that may occur at 
Table 3. N-Glycans Detected on s-gp130a
           native glycans        permethylated glycans              2AB-labeled glycans
                                              observed mass    expected mass   observed mass expected mass    observed mass    expected mass
proposed compositionb [M + Na]+ [M + Na]+        [M + Na]+    [M + Na]+           [M + Na]+         [M + Na]+
Hex8HexNAc4 2149.7 2149.7 2682.6 2682.3 2269.9 2269.8
Hex8HexNAc4dHex1 2295.8 2295.9 2856.8 2856.4 2415.8 2415.9
Hex8HexNAc4SO4 2251.7
c 2251.7c     2372.0c 2371.7c
Hex7HexNAc4 1987.7 1987.7     2107.9 2107.7
Hex7HexNAc4dHex1         2253.9 2253.8
Hex6HexNAc4dHex1         2091.8 2091.8
Hex9HexNAc3 2108.7 2108.7 2642.6 2641.3 2228.9 2228.8
Hex9HexNAc3SO4         2331.0
c 2330.7c
Hex8HexNAc3 1946.6 1946.7 2437.4 2437.2 2066.9 2066.7
Hex8HexNAc3dHex1 2092.8 2092.8 2614.4 2611.3 2212.7 2212.8
Hex8HexNAc3SO4         2168.9
c 2168.7c
Hex8HexNAc3MePO4 2063.6
c 2062.6c     2183.0d 2183.6d
          2160.9 2160.7
Hex7HexNAc3MePO4         1998.5 1998.6
Hex9HexNAc2     2396.4 2396.2 2026.1 2025.7
Hex8HexNAc2 1743.6 1743.6 2192.4 2192.1 1863.8 1863.6
a. Data are from MALDI-TOF-MS analyses of PNGase-released glycans.
b. Based on composition analyses (Table 2), Hex = Man, HexNAc = GlcNAc, dHex = Fuc.
c.	Ions	are	[M	+	2Na	−	H]+; also detected in - ion mode (see Figure 5).
d. Ions are a mixture of [M + Na]+	and	[M	+	2Na	−	H]+; also detected in - ion mode (see Figure 5).
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low abundance or ionize poorly in the presence of other gly-
cans, PNGase F-released, 2AB-labeled N-glycans were re-
solved by RP-HPLC. MALDI-TOF-MS analysis of fluorescent 
fractions confirmed the above glycans and provided fur-
ther evidence for sulfated and methyl-phosphorylated N-gly-
cans. For example, the positive ion spectrum of one fraction 
indicated sodiated H8N3−2AB and H9N3−2AB and, in addi-
tion, singly charged ions matching the m/z of H8N4SO4-2AB, 
H8N3SO4-2AB, H9N3SO4-2AB and H8N3MePO4-2AB (Figure 
5A). Each sulfated glycan was observed as a single disodiated-
H species, similar to previous results with sulfated glycans.50, 
51 A methyl-phosphorylated glycan was observed as a pair of 
ions corresponding to a sodium adducted only and sodium 
adducted with sodium-proton exchange equal to the number 
of phosphate groups, consistent with properties of reductively 
aminated (2-AEAB labeled) high mannose phosphomonoes-
ter standards.52, 53 In negative ion mode (Figure 5B), only [M 
− H]− ions corresponding to the sulfated or methyl-phosphor-
ylated glycans were observed, providing strong support for 
their postulated anionic nature. H8N4SO4-2AB and H8N3SO4-
2AB likely correspond to the GlcNAc-intersected and/or -bi-
sected Man8-species described above, with a 6-O−SO3-moiety 
on a peripheral Man as described previously for radiolabeled 
Dictyostelium glycans using non-MS methods.54 H8N3MePO4-
2AB likely represents Man8GlcNAc3MePO4-2AB, modified 
with a 6-MePO4-moiety on a peripheral Man, as also previ-
ously described on radiolabeled Dictyostelium glycans.55, 56 
Man8GlcNAc4SO4 and Man8GlcNAc3MePO4 were abundant 
enough to be detected in the positive ion mode profile of un-
derivatized s-gp130 N-glycans shown in Figure 3A.
Determination of Sites of Glycosylation of s-gp130.  Oc-
cupancy of potential glycosylation sites, or N-sequons, was as-
sessed using complementary strategies. Four nonglycosylated 
N-sequons were initially identified by detection of unglycosyl-
ated peptide ions in a tryptic digest, using MALDI-TOF-MS 
and confirmed by MS/MS analysis as summarized in Table S1 
(Supporting Information). Glycosylated sequons were iden-
tified by the appearance, after PNGase F treatment, of pep-
tides whose mass was increased by 0.98 Da due to the Asn to 
Asp conversion associated with glycan release. In the MALDI-
TOF-MS comparison of tryptic peptides from before and af-
ter PNGase F treatment shown in Figure S2 (Supporting In-
formation), new ions seen after deglycosylation were mapped 
to predicted tryptic fragments, and fragmentation by MALDI-
TOF/TOF or ESI-QTOF was performed to confirm the site of 
glycosylation. This approach led to the identification of seven 
glycopeptides (Table S1, Supporting Information). Treatment 
of the tryptic digest with Endo H, which leaves a residual 
GlcNAc tag, confirmed the findings and led to the identifica-
tion of an additional modified sequon (Table S1, Supporting 
Information). Detection of both nonglycosylated and modified 
versions of the same peptide indicated that these sequons are 
variably modified.
These approaches failed to detect peptides harboring 6 of 
the 18 N-sequons. To improve coverage, peptides were gen-
erated using pepsin or sequential addition of trypsin and chy-
motrypsin, and deglycosylated using PNGase A or PNGase F 
respectively. In addition, glycopeptides were pre-enriched us-
ing hydrophilic interaction chromatography or Con A lectin af-
finity chromatography (see Experimental Procedures) and de-
Figure 4. MS/MS of glycan H8N4−2AB with intersecting and bisecting GlcNAc residues. Fragmentation spectrum of H8N4−2AB ([M + Na]+ 
2269.9) after LID/heCID in a MALDI-TOF/TOF instrument showed abundant B- and Y-type fragment ions,49 which are interpreted by the 
proposed structure (inset) as described in the text.
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glycosylated using PNGase F in 50% H218O. Deglycosylated 
peptides (singly charged) were readily apparent as doublets 
(spaced by 2 Da), and subjected to MS/MS sequencing (data 
not shown). The status of each N-glycosylation site, inferred 
from these studies and from direct detection of glycopeptides 
as described in the next section, is summarized in Table 4. Evi-
dence was obtained for glycosylation of 15 of the 18 N-sequons. 
Seven sites were partially utilized and the remainder appeared 
to be fully occupied, though the possibility of their occasional 
non-utilization cannot be excluded. The partially utilized N-
sequons appear to be distributed throughout the length of the 
s-gp130 polypeptide (shown in blue in Figure 1).
Identification of Glycopeptide Glycans.  Glycopeptides 
were also detected directly, based on (1) mass matches with 
a conceptual [glycan+peptide] combinations, (2) occurrence 
of neutral losses of Hex, HexNAc, and/or Fuc in the MS/MS 
spectrum, (3) presence of glycan oxonium ions and [peptide + 
GlcNAc] as a dominant fragment ion in the MS/MS spectrum, 
(4) overlapping elution time with other glycopeptide glyco-
forms (see Figure 6 below), and (5) loss of the ion after PNGase 
A or PNGase F treatment. In some cases, midlevel confidence 
was based on satisfaction of the first and last criteria. As sum-
marized in Table 5, 60 distinct glycopeptides assignable to 14 
different N-sequons were directly identified using MALDI-
TOF/TOF-MS, LC-Q-TOF, and LC-LTQ instruments.
Two examples of high-level confidence assignments are 
shown in Figure S3. In panel A, a tryptic ion [m/z 1138.73 (+3)] 
was assigned as NIDFTNVTYMK with a Man9GlcNAc3 glycan 
at site 8. At the low mass end, the presence of sugar oxonium 
ions ([Hex − H2O + H]+, 162; [HexNAc − H2O + H]+, 204; [Hex2 
− H2O + H]+, 324) were indicative of a glycopeptide. At the 
higher end of the m/z range, fragmentation of the glycopeptide 
gave predominantly sequential losses of hexose residues until a 
fragment ion for the peptide and a single GlcNAc was observed. 
GlcNAc was assumed to be amide-linked to the side chain of 
the Asn in the single N-sequon (NVT) present on this peptide. 
In panel B, a tryptic/chymotryptic ion [m/z 1174.47 (+3)] was 
identified as FEQSITNLTTL modified with Man8GlcNAc4Fuc1 
at site 7. The presence of [peptide + GlcNAc]2+ and [peptide + 
GlcNAc + Fuc]2+ ions showed that Fuc is attached to the core 
GlcNAc, consistent with the glycomic results above.
The most prevalent glycoforms determined by the glycom-
ics analysis of s-gp130 (H8N4, H8N4F, H8N3, H8N3F, H9N2, 
and H8N2; Figure 3 and Table 3) were the most frequently ob-
served glycoforms on glycopeptides (Table 5). For example, 
H8N4 and H8N4F were detected at 6 and 7 sites, respectively, 
whereas the lower abundance glycoforms were often found at 
only one or two sites. In addition, glycans at individual sites 
were, in many cases, highly heterogeneous. For example, 12 
different glycans were detected at site 1 (NTT), including sev-
eral not detected in the glycomic approach. Eight were seen 
in a single LC−MS analysis of a tryptic/chymotryptic digest, 
as shown in the composite of all ions eluted in the interval 
from 13.8−14.8 min (Figure 6A). Most assignments were con-
firmed by MS/MS on individual scans such as shown in panel 
B. An example at m/z 1071.05 (H8N3F2) possessed a bisect-
ing GlcNAc and a core Fuc, based on detection of an H1N3F1-
peptide fragment ion. In addition, this and other structures in 
this series appeared to possess a previously described termi-
nal Man-linked Fuc,57, 58 based on a prominent fragment ion 
resulting from simultaneous loss of [Hex + dHex] from the 
parent ion (not shown). The glycopeptide characterizations 
confirmed that almost all glycans described in Table 4 were 
derived from s-gp130 rather than potential contaminants and, 
in addition, revealed previously undetected glycoforms.
Discussion
Dictyostelium N-Glycome.  The N-glycome of the amoe-
boid stage of D. discoideum consists predominantly of high-
Figure 5. Anionic N-glycans of s-gp130. PNGase F-released glycans were 2AB-labeled and fractionated by RP-HPLC. MALDI-TOF-MS analy-
sis of a fluorescent fraction containing candidate sulfated (S) and methyl-phosphorylated (MeP) N-glycans is shown in positive (A) and nega-
tive (B) ion modes. Glycan adduct types are as indicated, and comparisons with theoretical m/z values are listed in Table 3. See text for basis 
of structural predictions.
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mannose (Man6−9) structures whose cores are similar to those 
of the great majority of eukaryotes.21, 22, 11 The D. discoideum 
glycans are, however, specialized by modification with β4-
linked GlcNAc at the β-Man (bisecting), commonly observed 
for complex but not high-mannose N-glycans of animals, and 
at the Man α6-linked to the β4-Man (intersecting) which is 
novel. Fuc, an uncommon modification of high-mannose gly-
cans, occurs in α3-linkage (as in plants and invertebrates) and 
possibly in α6-linkage to the core GlcNAc, and on a periph-
eral Man. Substitution of peripheral Man residues with 6-O−
Figure 6. s-gp130 Glycopeptide Analysis using LC−MS/MS. Con A selected glycopeptides from a double digest (trypsin-chymotrypsin) were 
analyzed using LC-MS/MS (RP-HPLC on a Thermo LTQ XL). (A) Average MS spectrum of glycopeptides containing site 1 (QKNTTDPCLDN-
NMFTCK), during its elution (13.80−14.75 min) is shown. Eight glycoforms were detected, including H8N4, H8N4F, H7N4, H6N4F, H8N3, 
H8N3F, and H8N3SO4, which were observed in the glycomic analysis, and a novel doubly fucosylated H8N3F2. (B) Representative spectrum at 
14.08 min is shown to illustrate ions selected for MS/MS fragmentation (denoted by an *) in support of the structure models shown.
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SO3 or 6-O−PO3−Me is currently thought to be uncommon 
outside of the Dictyostelium lineage. The structures were orig-
inally defined in the 1980s and 1990s, by chromatographic 
analysis of changes effected by various exoglycosidases and 
selective chemical degradations, applied to PNGase F-, Endo 
H-, and hydrazinolysis- released glycans, or Pronase-released 
glycopeptides, derived from cells metabolically labeled with 
[3H]Man, [3H]GlcNH2, 35SO4, 32PO4, and other precursors.21, 57 
Very recently and while this study was in progress, mass spec-
trometry methods confirmed the occurrence of high-mannose 
N-glycans variably substituted with intersecting and bisect-
ing GlcNAc and core α3Fuc but, notably, core-α6-fucosylated, 
peripherally fucosylated, and anionic N-glycans were not de-
tected.22 Annotation of the D. discoideum genome revealed 
greater than 80 glycosyltransferase and glycophosphotransfer-
ase genes, over half of which probably contribute to formation 
of the N-glycome.59, 11
s-gp130 N-Glycome. This study characterizes the glycome 
of a single, extensively glycosylated cell surface protein, using 
mainly MS and MS/MS methods. The analysis was performed 
on a homologously expressed version of gp130 in which the 
C-terminal (presumptive GPI-anchor-directing) sequence was 
replaced with the myc-epitope tag. s-gp130 was purified es-
sentially to homogeneity based on chromatographic criteria 
and equivalence of silver staining and anti-gp130 labeling af-
ter SDS-PAGE (Figures 2A−C). Evidence was obtained for gly-
cosylation of 15 of the 18 N-sequons of s-gp130 (Table 4), and 
there was an average of 15 N-glycans/polypeptide. Analyses 
of N-glycans released enzymatically from s-gp130, which rep-
resented the great majority based on sugar composition analy-
sis, revealed predominantly a Man8GlcNAc4 structure (Figure 
3) possessing both bisecting and intersecting GlcNAc residues 
based on exoglycosidase digestions and MS/MS CID studies 
(Figure 4). A similar conclusion was drawn from 3 types of 
preparations (native, permethylated, and 2AB-derivatized), in-
dicating that the result was independent of method. Addition-
ally observed were lower abundance N-glycan types (Table 3) 
that spanned the range of the N-glycan substituents defined 
by the original glycomic analyses performed on isotopically 
labeled material as summarized above. In the neutral class, the 
number of Man residues ranged from 6−9, peripheral GlcNAc 
residues ranged from 0−2, and Fuc ranged from 0−2. Periph-
eral GlcNAc residues could be located at the bisecting or in-
tersecting positions or both (Figures 4, 6, and S3, Supporting 
Information). Fuc was predominantly α3-linked to the core 
GlcNAc, because most Fuc was resistant to release by PNGase 
F (Table 2 and Figure 3), indicating that it was not α6-linked 
to the core GlcNAc, the core α3-Fuc epitope was detected us-
ing an anti-HRP antibody (Figure 2D), and MS/MS studies lo-
cated Fuc on the core GlcNAc (Figure S3B, Supporting Infor-
mation). This assignment is consistent with results from the 
recent analysis of the total cellular N-glycome.22 However, 
Fuc in a peripheral linkage was also observed based on MS/
MS analysis of site 1 glycopeptides (Figure 6), consistent with 
trace levels of Fuc in PNGase F-released glycans (Table 2), and 
analysis of a difucosylated species on Site 1 (Figure 6) detected 
both core and peripheral Fuc. An average of 2 of the 14−16 N-
glycans of s-gp130 was inferred to be core α3-fucosylated, pri-
marily on GlcNAc-intersected and/or -bisected N-glycans.
Multiple anionic glycans also were detected (Figure 5). The 
assignment of three monosulfated species was based on mass 
matches in both the native glycan and 2AB-labeled pools, ion-
ization as a disodiated (with H-abstraction) species in positive 
ion mode, and selective detection in negative ion mode. The 
structures very likely correspond to the 6-O−SO3−Man mod-
ified N-glycans described previously.54 Methyl-phosphory-
lated 2AB-labeled N-glycans were assigned using similar cri-
teria, but were distinguished from sulfated glycans by their 
ionization as a mixture of monosodiated and disodiated spe-
cies in positive ion mode. These ions very likely correspond 
to a previously described55, 56 N-glycan with a peripheral 6-O−
MePO3−Man (phosphodiester) linkage. Phosphorylated gly-
Table 4.	Identification	of	s-gp130	Glycosylation	Sites
                                                                                     protease +                  pepsin +          trypsin +              Glycopeptide  
site                                                                               PNGase                      PNGase          Endo                      detected  
number    N-sequon         protease-treatmenta            F-treatmentb                         A-treatmentc    H-treatmentd          (Table 5)            Summarye
1 NTT   trypsin, chymo/trypf + + + +
2 NDT pepsin(NDT) trypsin(1)   +(1) +(1) +(1), +(2) ±g
3 NFS           ±g
4 NAT   trypsin     + +
5 NES           ?
6 NYS   trypsin   + + +
7 NLT pepsin       + ±
8 NVT trypsin trypsin + + + ±
9 NYS trypsin trypsin + + + ±
10 NYT   trypsin, chymo/tryp +   + +
11 NFS trypsin trypsin, chymo/tryp   +   ±
12 NVT   trypsin, chymo/tryp +   + +
13	 NKT	 pepsin	 		 −	 		 		 −
14 NDS   trypsin   + + +
15 NNS   trypsin   + + +
16 NVS pepsin   +   + ±
17 NIS   pepsin     + +
18	 NTT	 pepsin	 		 −	 		 		 −
a. Native peptide m/z (M + H)+ is observed after protease treatment (i.e., not glycosylated).
b. m/z increment of 0.98 is observed after PNGase F treatment following the protease treatment indicated.
c. m/z increment of 0.98 is observed after PNGase A treatment after pepsin digestion.
d. m/z increment of 203.1 is observed after Endo H treatment after trypsin digestion.
e.	+,	only	modified	peptides	detected;	±,	both	modified	and	unmodified	peptides	detected;	-,	only	unmodified	peptide	detected;	?,	peptide	not	detected.
f. Combined treatment with chymotrypsin and trypsin.
g. Sites 2 and 3, found on the same tryptic peptide, were observed to be simultaneously occupied, exclusively occupied, or alternatively occupied.
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cans lacking a methyl cap, and multiply phosphorylated and/
or sulfated species, were not detected. The absence of these an-
ionic structures in a recent MS study of total cell N-glycans22 
may be due to differences in methodologies, as ions corre-
sponding to these structures were abundant enough to be seen 
in a nonenriched glycomic profile of s-gp130 (Figure 3A).
s-gp130 N-Glycopeptidome.  The general features of the 
s-gp130 N-glycome inferred from enzymatically released N-
glycans were confirmed by direct analyses of the glycopep-
tides. Sixty glycopeptide ions associated with 14 glycosylation 
sites were assigned with varying degrees of confidence rang-
ing from exact mass matching to MS/MS-CID support (Table 
5, Figures 6 and S3, Supporting Information). Man8GlcNAc-
4Fuc0−1 species, which were the most abundant PNGase-re-
leased glycans, were also the most frequently observed modi-
fication, occurring at 10 different N-sequons. All but two of the 
PNGase-released glycan types were detected on the glycopep-
tides, confirming s-gp130 as their source; the two not observed 
(H7N4SO4 and H8N3MePO4) differ by only a single Man resi-
due. In contrast, 15 glycan types not revealed by the glycomic 
analyses were detected on peptides (compare Tables 5 and 3); 
most of the new glycans were however related by simple vari-
ations in the number of Man or GlcNAc residues. An excep-
tion was evidence for peripheral Man-linked Fuc (Figure 6) as 
described previously on radiolabeled material.57, 58 An even 
greater diversity of glycan types cannot be excluded but, since 
all major types defined by earlier studies using metabolic la-
beling were observed, novel glycans are likely to be related 
and of low abundance if they exist at all. Thus the glycopro-
teomic approach was better at revealing the diversity of gly-
cosylation, whereas the glycomic approach was more suitable 
for revealing the relative abundance of glycan types.
Individual sites varied greatly in their modification status. 
Sites 1 and 8 were modified with up to 12 different glycans (Ta-
ble 5), whereas only a single minimally processed glycan (Man-
8GlcNAc2) was found at site 15. Methyl-phosphodiester N-gly-
cans were observed at five sites and sulfated N-glycans were 
at four partially overlapping sites, suggesting preferential sites 
for anionic modification, and a peripheral Fuc residue was ob-
served at only site 1. In addition, seven sites exhibited variable 
occupancy and two sites appeared unoccupied (Table 4). Fail-
ure to modify Site 18 may be an artifact of its proximity to the C-
terminus in the secreted construct. The mechanisms behind site-
specific variations are not known as structure information is not 
available for this glycoprotein. In summary, gp130 consists of 
thousands of glycoforms if heterogeneity at different sites is in-
dependent. These findings are consistent with an average site 
occupancy of 15 (of 18 total) for the full-length protein based on 
results from Table 1 and Figure 2C and F.
Relevance to gp130. The N-glycosylation features observed 
on s-gp130 are potentially applicable to native gp130, because 
SDS-PAGE/Western blot analysis revealed a similar if not iden-
tical degree of N-glycosylation (Figure 2E), and a comparison 
after Endo H-digestion indicated a similar fraction of resistant 
N-glycans (Figure 2F) that are likely core α3-fucosylated. In ad-
dition, the most highly reactive band for anti-core α3Fuc in veg-
etative cells and in an n-butanol extract of vegetative cells, en-
riched in gp130 and other GPI-anchored proteins25 consistent 
with the sequence prediction that gp130 is GPI-anchored, comi-
grated with gp130. Thus, authentic gp130 appears to not only 
be core-fucosylated as for s-gp130, but may also be the major 
carrier of this structure in amoebae. Interestingly, N-glycans 
from the n-butanol pool were generally more fucosylated than 
from other cell fractions (data not shown), raising the possibil-
ity that N-glycans of authentic gp130 are more fucosylated than 
those from s-gp130. However, confirmation of the profile of N-
glycan structures on gp130 itself must await an efficient method 
to isolate the native glycoprotein. No O-glycans were detected 
in searches of material released by alkaline treatment, or in the 
glycopeptides, consistent with the absence of Mr shifts in modB- 
and modC mutant strains that affect O-glycosylated spore coat 
proteins (Figure 2E).
Though Man8GlcNAc4 was abundant in total amoeba N-
glycans in a recent MS analysis, it was less prevalent than 
species with fewer Man residues and/or with core α3-Fuc.22 
Therefore, although s-gp130 expresses a broad cross-section 
of the N-glycome, the skewed abundance profile of N-glycan 
types is indicative of protein- or compartment-specific special-
ization of s-gp130 N-glycan processing, in addition to site-spe-
cific processing as summarized above.
Potential Relevance to the Cell Surface Glycocalyx.  gp130 
is related to a family of 15 predicted proteins, as inferred from 
analysis of genome sequences and from biochemical stud-
ies (Table 6). These are all large proteins that exhibit 28−40% 
sequence identity and 38−48% similarity to gp130, and pos-
sess predicted signals for import into the rER and for GPI-
anchor addition. They each encode 4−31 N-sequons, with all 
but two having 9 or more. A major subfamily consists of the 
four gp138 glycoproteins, which are more similar to each other 
(82−87% similarity and 77−85% identity using BESTFIT and 
GAP60) than to gp130. gp138 was originally implicated in sex-
ual cell fusion events leading to the formation of macrocysts 
by D. discoideum,7, 61 but tetra-knockout cells produce macro-
cysts leaving the function of the gp138 family unclear.8 Strik-
ingly, the positions of the N-glycans are poorly conserved in 
this protein family (Table 6).
Relatives of these genes also occur in the genome sequence 
of D. purpureum,11 where the family is dramatically smaller 
with six predicted members that fulfill length and similarity 
criteria. The D. purpureum homologues also are predicted to 
be highly N-glycosylated, but again at unconserved sites com-
pared to gp130 and to each other (Table 6). Although gener-
ally similar in length and identity to the D. discoideum homo-
logues, the D. purpureum members are sufficiently diverged 
that it is difficult to assign orthologs. Overall, the protein se-
quences of the gp130/gp138 family are much more highly di-
verged between the species than for the vast majority of other 
related genes.11 The low amino acid sequence conservation, to-
gether with predicted high N-glycan density but poor position 
conservation, suggests that a primary function of gp130 family 
members is to present a spectrum of N-glycans at the cell sur-
face. The glycan heterogeneity at specific sites is suggestive of 
a greater importance for contributing to the general glycoca-
lyx10 at the cell surface than providing protein- or domain-spe-
cific functions for gp130. Recent evidence that the spectrum of 
N-glycans expressed by D. purpureum overlaps little with that 
of D. discoideum11 is consistent with species-specific functions 
for the postulated N-glycan shroud, which correlates with spe-
cies segregation in cell mixtures and cell level differences in 
kin selection that have been noted.62, 63
The high degree of similarity of N-glycans among eu-
karyotes has its origin in the conservation of the structure of 
the lipid-linked Glc3Man9GlcNAc2- precursor, which is in-
volved in nascent protein folding, quality control, and ERAD 
in the rER.64 Like most organisms, Dictyostelium, a nonwalled 
amoeba, imparts its own species-specific modifications, here 
in the form of limited mannose-processing, intersecting and/
or bisecting GlcNAcs, peripheral MePO4 and SO4, and periph-
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Table 5.	Identification	of	s-gp130	Glycopeptides
                                          peptide                          glycopeptide                       predicted                     criteriab/ 
site #    N-sequon           m/z predicted     m/z observeda     m/z predicted       glycan                          protease                    peptide sequencec
1 NTT 2086.9 1049.0(+4) 1049.7 H8N4 ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 1085.5(+4) 1086.2 H8N4F ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 999.6(+4) 998.9 H8N3 ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 1035.0(+4) 1035.4 H8N3F ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 1004.8(+4) 1004.9 H6N4F ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 1009.2(+4) 1009.2 H7N4 ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 1018.4(+4) 1018.9 H8N3SO4 ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    2086.9 1071.3(+4) 1071.3 H8N3F2 ++/chymo,tryp Y/QKNTTDPCLDNNMFTCK
    1832.7 3655.6 3656.3 H7N3SO4 +/trypsin K/NTTDPCLDNNMFTCK
    2931.3d 4309.8 4310.0 H6N2 +/trypsin K/DLYYQIYQKNTTDPCdLDNNMFTCdK
    2931.3d 4821.0 4821.1 H7N3F +/trypsin K/DLYYQIYQKNTTDPCdLDNNMFTCdK
    3047.3 5195.0 5194.4 H9N3SO4 +/trypsin K/DLYYQIYQKNTTDPCLDNNMFTCK
2 NDT 1002.6 2543.2 2543.5 H7N2 +/pepsin L/GLKKNNDTL
2,3 NDT/NFS 1898.0 6338.5 6338.5 H8N4F, H8N4SO4 +/pepsin K/NNDTLSIITNANFSVFK
    1322.7 1144.6(+3) 1144.5 H8N4 ++/chymo,tryp N/NDTLSIITNANF
    1322.7 1192.5(+3) 1193.2 H8N4F ++/chymo,tryp N/NDTLSIITNANF
4 NAT 929.5 1519.3(+2) 1519.6 H8N4 ++/chymo,tryp F/SVFKNATY
    929.5 1498.8(+2) 1499.1 H8N3 ++/chymo,tryp F/SVFKNATY
    929.5 1398.0(+2) 1397.6 H9N2 ++/chymo,tryp F/SVFKNATY
    1503.9 3666.0 3665.6 H9N3MePO4 +/pepsin F/KNATYILIGDGIIL
5 NES   ND        
6 NYS 1489.7 3338.4 3338.8 H8N2F +/trypsin K/NYSFPTFQPFNK
    1489.7 3327.3 3327.7 H7N3MePO4 +/trypsin K/NYSFPTFQPFNK
7 NLT 1266.6 1125.6(+3) 1125.5 H8N4 ++/chymo,tryp N/FEQSITNLTTL
    1266.6 1174.5(+3) 1174.2 H8N4F ++/chymo,tryp N/FEQSITNLTTL
8 NVT 1345.5 1016.7(+3) 1016.8 H8N2 ++/trypsin K/NIDFTNVTYMK
    1345.5 1070.7(+3) 1070.7 H9N2 ++/trypsin K/NIDFTNVTYMK
    1345.5 1084.7(+3) 1084.5 H8N3 ++/trypsin K/NIDFTNVTYMK
    1345.5 1138.8(+3) 1138.5 H9N3 ++/trypsin K/NIDFTNVTYMK
    1345.5 1200.5(+3) 1200.8 H8N4F ++/trypsin K/NIDFTNVTYMK
    1441.7 1572.2(+2) 1572.7 H8N2 ++/chymo,tryp F/NIKNIDFTNVTY
    1441.7 1673.7(+2) 1674.2 H8N3 ++/chymo,tryp F/NIKNIDFTNVTY
    1441.7 1653.4(+2) 1653.7 H9N2 ++/chymo,tryp F/NIKNIDFTNVTY
    1605.7 3349.4 3349.9 H7N3 +/pepsin F/TNVTYMKMQNNDF
    1605.7 3636.4 3636.3 H7N4MePO4 +/pepsin F/TNVTYMKMQNNDF
9 NYS 2312.0 1392.1(+3) 1392.9 H9N2 ++/chymo,tryp F/EQELPTNEGGDSSNINYSTTR
    812.3 1534.5(+2) 1534.1 H8N4F ++/chymo,tryp G/DSSNINY
10 NYT 3233.6 5487.2 5488.3 H8N4F ++/trypsin K/YPTLSYNELTGEIPTCFSCMGANYTITK
    3233.6 4920.1 4920.0 H7N2F +/trypsin K/YPTLSYNELTGEIPTCFSCMGANYTITK
    1188.5d 1527.6(+2) 1527.1 H9N2 ++/chymo,tryp F/SCdMGANYTITK
    1245.6 1555.8(+2) 1555.6 H9N2 ++/chymo,tryp F/SCMGANYTITK
    1188.5d 1446.1(+2) 1446.1 H8N2 ++/chymo,tryp F/SCdMGANYTITK
    1245.6 1474.5(+2) 1474.6 H8N2 ++/chymo,tryp F/SCMGANYTITK
11 NFS   ND        
12 NVT 1230.6 3177.4 3177.9 H7N4 +/pepsin F/SLPSGNNDNNVTL
    1230.6 3433.3 3433.9 H8N4MePO4 +/pepsin F/SLPSGNNDNNVTL
    1230.6 3419.3 3419.7 H8N4SO4 +/pepsin F/SLPSGNNDNNVTL
    1030.5 3192.2 3192.5 H9N3MePO4 +/pepsin L/PSGNNDNNVTL
    1030.5 2570.8 2571.1 H7N2 +/pepsin L/PSGNNDNNVTL
13 NKT   ND        
14 NDS 2781.3 4821.9 4821.1 H7N3MePO4 +/trypsin K/FSQTFTYSYEIPVITSYSFGNDSK
    1064.5 1587.2(+2) 1587.1 H8N4 ++/chymo,tryp Y/SFGNDSKFY
    901.4 1403.6(+2) 1404.0 H8N3 ++/chymo,tryp Y/SFGNDSKF
    901.4 1505.3(+2) 1505.6 H8N4 ++/chymo,tryp Y/SFGNDSKF
    901.4 1578.2(+2) 1578.6 H8N4F ++/chymo,tryp Y/SFGNDSKF
15 NNS 1642.8 1116.3(+3) 1115.8 H8N2 ++/chymo,tryp F/SFINNNSITLNGVSY
16 NVS 1704.9 3325.4 3325.8 H7N2SO4 +/pepsin F/NVSINVGNQVSNIVTF
    1704.9 3553.6 3553.6 H8N2F +/pepsin F/NVSINVGNQVSNIVTF
17 NIS 1311.7 3363.0 3363.4 H8N3F +/pepsin L/NISGSSSLVTVTF
    764.4 3019.0 3019.2 H8N4F +/pepsin L/NISGSSSL
    1733.0 1213.9(+3) 1213.8 H8N3 ++/chymo,tryp S/LSNNKLNISGSSSLVTV
    1733.0 1262.4(+3) 1262.4 H8N3F ++/chymo,tryp S/LSNNKLNISGSSSLVTV
    1733.0 1281.1(+3) 1281.2 H8N4 ++/chymo,tryp S/LSNNKLNISGSSSLVTV
18 NTT   ND        
a. Ions are [M + H]+ except as indicated, and multicharged ions are multiprotonated; singly charged ions are from MALDI- experiments and multi-
charged ions are from QSTAR Elite (tryptic digests) or LTQ XL (all other) experiments; ND, not detected.
b.	++,	high	confidence	assignment;	tryptic	glycopeptides:	mass	match,	tryptic	peptide	seen	after	PNGase	F	digestion,	MS/MS	detected	glycan	ox-
onium	and	peptide	ions;	tryptic/chymotryptic	glycopeptides:	mass	match,	MS/MS	detected	[peptide+GlcNAc]	ion	and	confirmed	reported	gly-
can;	and	coelution	with	other	glycoforms	in	LC-MS	+,	midlevel	confidence	assignment;	tryptic	glycopeptides:	mass	match,	peptide	seen	after	
PNGase	F	digestion;	peptic	glycopeptides:	mass	match,	peptide	seen	after	PNGase	A	digestion	(no	MS/MS	confirmation).
c. Slash indicates peptide N-terminal cleavage site; N-sequon is bolded.
d. Except as noted by this superscript, Cys residues were alkylated with iodoacetamide.
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eral and core α3-fucosylation. This study confirms the occur-
rence of these previously described glycans on a high abun-
dance cell surface protein, and reveals that site heterogeneity 
is as extensive in this amoeba as it is in higher animals.65 It is 
remarkable that simple variants of high-mannose N-glycans 
are as suitable for cellular life in soils around the world as they 
are for stem cells (whose N-glycome approaches 50% high 
mannose content) residing in the tissue beds of multicellular 
organisms.66, 67 Future studies are needed to address how spe-
cializations of the high-mannose amoeba glycans as defined 
here for gp130 and more broadly for total N-glycans, influence 
intraspecific, interspecific and predator−prey interactions of 
social amoebae in their native habitats.
Abbreviations 
2AB, 2-aminobenzamide
ACN, acetonitrile
CID, collision-induced dissociation
Con A, Concanavalin A
ESI-QTOF, electrospray ionization-quadrupole time-of-flight mass 
spectrometry
Fuc, l-fucose (pyranose form)
GlcNAc, N-acetyl-d-glucosamine (pyranose)
GPI, glycophosphatidylinositol
H8N4, a glycan species with a composition of 8 Hex and 4 
HexNAc residues
HexNAc, N-acetylhexosamine
HPAEC, high pH anion exchange chromatography
HPLC, high pressure liquid chromatography
mAb, monoclonal antibody
MALDI-TOF/TOF-MS, matrix-assisted laser desorption ionization 
time-of-flight (dual-stage) mass spectrometry
Man, d-mannose
PAD, pulsed amperometric detection
PNGase F, peptide−N4-N-acetyl-beta-d-glucosaminyl)-asparagine 
amidase
RP, reversed-phase; s-gp130, recombinant soluble form of gp130
DMSO, dimethylsulfoxide
TFA, trifluoroacetic acid
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Supplemental Table S1. Glycosylation site mapping of tryptic glycopeptides
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Supplemental Figure S1. Exoglycosidase digestion of s-gp130 glycans. Glycan composition and linkage positions of the GlcNAc residues 
were examined before and after exoglycosidase digestion of RP-HPLC purified H8N4-2AB and H9N3-2AB glycans by MALDI-TOF-MS (as 
in Figure 3B). A) Spectrum of H8N4-2AB with suspected intersecting and bisecting GlcNAcs before digestion. B) H8N4-2AB after Jack Bean 
α-mannosidase digestion. Three major products are observed (H7N4-2AB, H6N4-2AB, and H5N4-2AB). Most likely structures are depicted 
(see text). The glycan was unaffected by β-hexosaminidase digestion (data not shown), consistent with location of GlcNAcs at branch points 
that also protect neighboring mannose residues from α-mannosidase release. C) Spectrum of H9N3-2AB. Two likely configurations (intersect-
ing and bisecting) are shown. D) α-mannosidase digestion of H9N3-2AB yielded three glycans (H6N3-2AB, H5N3-2AB, H4N3-2AB). H4N3-
2AB is most consistent with an intersecting configuration, but both intersecting and bisecting possibilities are shown. Ions at m/z 2224.9, 
1373.9, 1259.0, and 1233.9 represent non-dialyzable contaminants from the enzyme preparation (data not shown). All ions are singly charged 
[M+Na]+.
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Supplemental Figure S2. MALDI-TOF-MS analysis in linear positive mode of s-gp130 tryptic peptides before (A) and after (B) PNGase F 
digestion. The upper inset (top panel) compares the high mass range containing PNGase F-sensitive peptides, and the lower inset (bottom 
panel) compares the low mass range showing novel peptides that appeared after PNGase F treatment.
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Supplemental Figure S3. MS/MS fragmentation of s-gp130 glycopeptides. A) A tryptic glycopeptide, identified as 
NIDFTNVTYMK+GlcNAc3Man9 ([M+3H]+3=m/z 1138.76) containing site 8, was fragmented using CID in a QSTAR-Elite, which revealed 
the sequential loss of 6 mannose residues, the peptide+GlcNAc ion, and glycan oxonium ions in low mass range. B) a chymotryptic glycopep-
tide, identified as FEQSITNLTTL+H8N4F1 ([M+3H]+3=m/z 1147.47) containing site 7, was fragmented by CID on a Thermo-Electron LTQ 
XL. The glycopeptide showed sequential losses of HexNAc, Hex, and dHex, depending on the charge state. dHex (Fuc) was linked to core 
GlcNAc based on presence of the [peptide+GlcNAc+Fuc] ion (m/z 807.44).
